US FDA Approves Pfizer's Biosimilar, Abrilada for Multiple Inflammatory Conditions

ORION-9 Study of Inclisiran in HeFH Patients Showed Durable and Potent LDL-C Lowering with Twice-Yearly Dosing

BioArctic's interim analysis of phase 1/2 study of SC0806 in patients with CSC injury halts spinal cord injury project

Recipharm announces new financial targets for 2020 on Capital Markets Day

Cantargia's novel preclinical data on antibody CAN04 to be presented at PEGS Europe conference in Portugal

BioPorto to provide additional patient information to US FDA for regulatory clearance of The NGAL Test for paediatric risk assessment of AKI

European Commission grants approval to AstraZeneca's diabetes drug Qtrilmet

US FDA grants approval to Novartis' Adakveo

Cerveau Technologies Starts Japanese Phase I Study

Cantargia's pre-IND meeting with US FDA results in advancement of development of antibody CAN04

EpicentRx raises USD35m in Series D financing

US FDA grants AstraZeneca and Merck New Drug Application and priority review for Selumetinib

US FDA Accepts Regulatory Submission of New Drug Application for Selumetinib in Neurofibromatosis Type 1 and Grants Priority Review

PredictImmune Names Clark as Chief Technology Officer

Birgitta Stymne Göransson Elected Member of LEO Pharma's Board of Directors